Harvard Bioscience Inc (HBIO)
3.85
+0.03
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
3.89
+0.04
(+1.04%)
Pre-Market: 20:00
Harvard Bioscience Accounts Receivable (Quarterly): 16.10M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.10M |
September 30, 2023 | 14.98M |
June 30, 2023 | 16.90M |
March 31, 2023 | 17.74M |
December 31, 2022 | 16.70M |
September 30, 2022 | 15.02M |
June 30, 2022 | 17.85M |
March 31, 2022 | 20.27M |
December 31, 2021 | 21.83M |
September 30, 2021 | 18.34M |
June 30, 2021 | 17.39M |
March 31, 2021 | 17.07M |
December 31, 2020 | 17.77M |
September 30, 2020 | 13.88M |
June 30, 2020 | 14.71M |
March 31, 2020 | 15.42M |
December 31, 2019 | 20.70M |
September 30, 2019 | 17.08M |
June 30, 2019 | 18.39M |
March 31, 2019 | 18.79M |
December 31, 2018 | 21.46M |
September 30, 2018 | 17.88M |
June 30, 2018 | 19.59M |
March 31, 2018 | 18.96M |
December 31, 2017 | 13.38M |
Date | Value |
---|---|
September 30, 2017 | 15.27M |
June 30, 2017 | 15.98M |
March 31, 2017 | 15.48M |
December 31, 2016 | 15.75M |
September 30, 2016 | 15.12M |
June 30, 2016 | 16.35M |
March 31, 2016 | 18.02M |
December 31, 2015 | 17.55M |
September 30, 2015 | 15.59M |
June 30, 2015 | 18.54M |
March 31, 2015 | 16.02M |
December 31, 2014 | 16.14M |
September 30, 2014 | 14.28M |
June 30, 2014 | 14.31M |
March 31, 2014 | 14.32M |
December 31, 2013 | 13.88M |
September 30, 2013 | 13.36M |
June 30, 2013 | 13.83M |
March 31, 2013 | 14.19M |
December 31, 2012 | 14.36M |
September 30, 2012 | 13.60M |
June 30, 2012 | 15.07M |
March 31, 2012 | 16.17M |
December 31, 2011 | 15.08M |
September 30, 2011 | 13.62M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
13.88M
Minimum
Sep 2020
21.83M
Maximum
Dec 2021
17.27M
Average
17.08M
Median
Sep 2019
Accounts Receivable (Quarterly) Benchmarks
Bruker Corp | 475.40M |
Azenta Inc | 155.93M |
Bionano Genomics Inc | 9.319M |
Akoya Biosciences Inc | 16.99M |
Singular Genomics Systems Inc | 0.565M |